U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Cover of Skin care advice for people with acne vulgaris

Skin care advice for people with acne vulgaris

Acne vulgaris: management

Evidence review B

NICE Guideline, No. 198

.

London: National Institute for Health and Care Excellence (NICE); .
ISBN-13: 978-1-4731-4147-6

Skin care advice for people with acne vulgaris

Review question

What skin care advice is appropriate for people with acne vulgaris?

Introduction

People with acne vulgaris need to look after their skin. This will include day-to-day care of the skin, for example cleansing, applying a moisturiser or a sunscreen and when necessary using active medical treatments. Effective skin care is of particular importance for people with acne vulgaris as it will help to ameliorate the effects of treatment and reduce the likelihood of everyday products worsening acne.

Summary of the protocol

Please see Table 1 for a summary of the Population, Intervention, Comparison and Outcome (PICO) characteristics of this review.

Table 1. Summary of the protocol.

Table 1

Summary of the protocol.

For further details see the review protocol in appendix A.

Methods and process

This evidence review was developed using the methods and process described in Developing NICE guidelines: the manual. Methods specific to this review question are described in the review protocol in appendix A and the methods document (supplementary document 1).

Declarations of interest were recorded according to NICE’s conflicts of interest policy.

Clinical evidence

Included studies

Overall three randomised controlled trials (RCTs) were included in this review, of which 2 were parallel group studies (Korting 1995, Santos-Caetano 2019) and 1 was a split-face trial (Choi 2010).

One study was conducted in South Korea (Choi 2010), 1 in Germany (Korting 1995) and 1 in the USA (Santos-Caetano 2019). All studies included both men and women. Two studies focused on people with mild acne vulgaris (Choi 2010, Korting 1995) and 1 on mild to moderate acne vulgaris (Santos-Caetano 2019). The sample size of the studies ranged from 13 to 122 participants.

All included studies compared different types of skincare products. One parallel-group study compared an acidic syndet (short for synthetic detergent which had a pH in solution: 5.5 to 5.6) bar called ‘Sebamed compact’ to a conventional ‘Lux’ soap bar (Korting 1995), whilst another compared reformulated 4% and 10% benzoyl peroxide face washes to an older (and no longer commercially available) 10% formulation face wash (Santos-Caetano 2019). One split-face study compared an enhanced face cleanser containing papain, proteomax, soap powder and 0.04% triclosan, 1% salicylic acid and 1% azelaic acid to a cleanser containing papain, proteomax and soap powder only (Choi 2010).

Evidence was identified for some outcomes such as change in acne severity (change in inflammatory and non-inflammatory lesion counts), skin-related adverse events and satisfaction with the study product.

No evidence was identified for self-reported change of acne severity and skin-specific quality of life. The included studies are summarised in Table 2.

Excluded studies

Studies not included in this review are listed, and reasons for their exclusion are provided in appendix K.

Summary of clinical studies included in the evidence review

Summaries of the studies that were included in this review are presented in Table 2.

Table 2. Summary of included studies.

Table 2

Summary of included studies.

See the full evidence tables in appendix D. No meta-analysis was conducted (and so there are no forest plots in appendix E).

Quality assessment of clinical studies included in the evidence review

See the evidence profiles in appendix F.

Economic evidence

Included studies

A single economic search was undertaken for all topics included in the scope of this guideline but no economic studies were identified which were applicable to this review question. See the literature search strategy in appendix B and economic study selection flow chart in appendix G.

Excluded studies

No economic studies were reviewed at full text and excluded from this review.

Economic model

No economic modelling was undertaken for this review because the committee agreed that other topics were higher priorities for economic evaluation.

The committee’s discussion of the evidence

Interpreting the evidence
The outcomes that matter most

Change of acne severity during and at the end of treatment (investigator reported or self-reported, reduction in inflammation and number of acne lesions) were prioritised by the committee as critical outcomes because they indicate whether the treatment is efficacious. Disease-specific health-related quality of life was another critical outcome because it indicates whether the person with acne vulgaris perceives an improvement in acne symptoms. Skin-related adverse events were chosen as a critical outcome and satisfaction with treatment as an important outcome because they indicate whether the intervention is safe in the short-term and the acceptability of the intervention.

The quality of the evidence

The quality of the evidence ranged from very low to moderate, with most of the evidence being of a low quality. This was predominately due to risk of bias of individual studies and imprecision of the effect estimates. Two studies were sponsored by industry.

Benefits and harms

Overall, the evidence on the use of skin care products was very limited. The committee recommended that advising the use of a syndet skin cleansing product for acne vulgaris affected areas, ideally twice daily, should be considered as the evidence suggests that this reduces inflammatory and non-inflammatory acne lesion counts. These bars have a non-alkaline (skin pH neutral or slightly acidic), whereas traditional soap bars are alkaline, therefore syndet skin cleansing products are less irritant to the skin than traditional soap bars. The committee also discussed that, although the research was carried out on a syndet bar, many syndets are now available in different formulations such as liquid or foam, and they agreed that different formulations are probably similarly effective. The committee discussed that the costs of syndets varies and noted that it would be reasonable to try the cheapest syndet in the first instance.

No relevant evidence on the use of other skin-care products such as oil-free products or make-up was identified. However, the committee agreed that it was important to say something about the use of skin care products as many people affected by acne vulgaris are concerned about them. Therefore, based on their knowledge and experience, they recommended that people with acne vulgaris should be advised to avoid applying oil-based and comedogenic (i.e. likely to block pores) products whenever possible as these could worsen their acne vulgaris. They agreed that oil-based and comedogenic skin care products (moisturisers and sunscreens) should be avoided. They also recommended that people with acne vulgaris using make-up should be advised to avoid oil-based and comedogenic products and to remove make-up at the end of the day. They discussed that in their experience oil-based and comedogenic products can make acne vulgaris worse because acne is typified by excessively oily skin and skin prone to blockage of pores. The committee discussed what to use for make-up removal. They agreed that this could be part of skin cleansing advice, using a non-alkaline (skin pH neutral or slightly acidic) syndet or in addition to it, if it is a specific area of the face (as in removal of eye make-up) or a specific type of make-up (for example long lasting make-up used in theatres) which may require a different type of cleanser. Given the lack of evidence, the committee decided that they could not be prescriptive about the products that should be used for make-up removal.

There was limited evidence of low quality on the use of acidic skin cleansers and benzoyl peroxide-based face washes. Although there was moderate quality evidence for the outcome of participants satisfied or very satisfied with the benzoyl peroxide from 1 study, the committee agreed that a recommendation could not be made based on this outcome.

Furthermore, there was little evidence of benefit for other outcomes based on low quality evidence. Therefore, the committee did not make a recommendation about these products.

The committee discussed whether a research recommendation should be made for this topic. Clinicians are frequently asked for advice regarding skin care, such as what is appropriate and effective in people with acne vulgaris. Therefore, it is an important topic for people with acne vulgaris. Due to the limited evidence the committee decided to prioritise this for a research recommendation (see appendix L).

Cost effectiveness and resource use

No economic evidence was identified for this review question. The recommendations made by the committee have minimal healthcare resource implications comprising health professionals’ time to provide advice. The types of products advised for use are generic and thus incur small costs to people with acne. As skin care products are generally paid for by the person with acne, there are no costs to the health service.

Recommendations supported by this evidence review

This evidence review supports recommendations 1.2.1 to 1.2.3 (recommendation 1.2.4 is supported by evidence from evidence report L- risk factors for scarring) and research recommendation 4 on skin care advice in the guideline.

References

  • Choi 2010

    ChoiYS, SuhHS, YoonMY, MinSU, KimJS, JungJYet al. A study of the efficacy of cleansers for acne vulgaris. J Dermatolog Treat2010, 21(3):201–5 [PubMed: 20394494]
  • Korting 1995

    KortingHC, Ponce-PöschlE, KlövekornW, SchmötzerG, Arens-CorellM, Braun-FalcoO. The influence of the regular use of a soap or an acidic syndet bar on pre-acne. Infection1995, 23(2):89–93 [PubMed: 7622270]
  • Santos-Caetano 2019

    Santos-CaetanoJP, CargillMR. A Randomized Controlled Tolerability Study to Evaluate Reformulated Benzoyl Peroxide Face Washes for Acne Vulgaris. J Drugs Dermatol2019, 18(4):350–356 [PubMed: 31012563]

Appendices

Appendix A. Review protocol

Review protocol for review question: What skin care advice is appropriate for people with acne vulgaris?

Table 3. Review protocol for skin care advice for people with acne vulgaris (PDF, 299K)

Appendix E. Forest plots

Forest plots for review question: What skin care advice is appropriate for people with acne vulgaris?

This section includes forest plots only for outcomes that are meta-analysed. No meta-analysis was conducted for this review question and so there are no forest plots.

Appendix H. Economic evidence tables

Economic evidence tables for review question: What skin care advice is appropriate for people with acne vulgaris?

No economic evidence was identified which was applicable to this review question.

Appendix I. Health economic evidence profiles

Economic evidence profiles for review question: What skin care advice is appropriate for people with acne vulgaris?

No economic evidence was identified which was applicable to this review question.

Appendix J. Economic analysis

Economic analysis for review question: What skin care advice is appropriate for people with acne vulgaris?

No economic analysis was conducted for this review question.

Appendix K. Excluded studies

Excluded clinical and economic studies for review question: What skin care advice is appropriate for people with acne vulgaris?

Economic studies

No economic evidence was identified for this review.

Final

Evidence review underpinning recommendations 1.2.1 to 1.2.3 (recommendation 1.2.4 is underpinned by evidence review L) and research recommendation 4 in the NICE guideline

These evidence reviews were developed by the National Guideline Alliance which is a part of the Royal College of Obstetricians and Gynaecologists

Disclaimer: The recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. When exercising their judgement, professionals are expected to take this guideline fully into account, alongside the individual needs, preferences and values of their patients or service users. The recommendations in this guideline are not mandatory and the guideline does not override the responsibility of healthcare professionals to make decisions appropriate to the circumstances of the individual patient, in consultation with the patient and/or their carer or guardian.

Local commissioners and/or providers have a responsibility to enable the guideline to be applied when individual health professionals and their patients or service users wish to use it. They should do so in the context of local and national priorities for funding and developing services, and in light of their duties to have due regard to the need to eliminate unlawful discrimination, to advance equality of opportunity and to reduce health inequalities. Nothing in this guideline should be interpreted in a way that would be inconsistent with compliance with those duties.

NICE guidelines cover health and care in England. Decisions on how they apply in other UK countries are made by ministers in the Welsh Government, Scottish Government, and Northern Ireland Executive. All NICE guidance is subject to regular review and may be updated or withdrawn.

Copyright © NICE 2021.
Bookshelf ID: NBK573057PMID: 34424620

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.1M)

Related NICE guidance and evidence

Supplemental NICE documents

Related information

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...